BG103395A - Производни на бензенсулфонамида и лекарства, които ги съдържат - Google Patents

Производни на бензенсулфонамида и лекарства, които ги съдържат

Info

Publication number
BG103395A
BG103395A BG103395A BG10339599A BG103395A BG 103395 A BG103395 A BG 103395A BG 103395 A BG103395 A BG 103395A BG 10339599 A BG10339599 A BG 10339599A BG 103395 A BG103395 A BG 103395A
Authority
BG
Bulgaria
Prior art keywords
benzenesulphonamide
alkyl group
medicaments containing
derivatives
group
Prior art date
Application number
BG103395A
Other languages
English (en)
Inventor
Shingo Yasuda
Nobuo Ogawa
Shuhichiro Sukurai
Original Assignee
Hokuriku Seiyaku Co.,Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Seiyaku Co.,Ltd filed Critical Hokuriku Seiyaku Co.,Ltd
Publication of BG103395A publication Critical patent/BG103395A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Лекарствата, съдържащи производни на бензенсулфонамида като активен ингредиент, могат да се използват за превантивна и/или лечебна терапия на тромбоза, астма или алергични заболявания. Те имат обща формула, в която R1 означава водороден атом, халогенен атом, нисша алкилова група, нисша алкоксилна група или нитрогрупа, R2 - С4-С8 алкилова група, която е заместена с един или повече флуорни атома, R3 - водороден атом или нисша алкилова група, Х е серен атом или група СН = СН и n е цяло число от 2 до 4.
BG103395A 1996-11-13 1999-05-12 Производни на бензенсулфонамида и лекарства, които ги съдържат BG103395A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31710996 1996-11-13
JP9269234A JPH10195038A (ja) 1996-11-13 1997-09-16 ベンゼンスルホンアミド誘導体及びそれを含有する医薬
PCT/JP1997/004125 WO1998021177A1 (fr) 1996-11-13 1997-11-12 Derives benzenesulfonamide et medicaments les contenant

Publications (1)

Publication Number Publication Date
BG103395A true BG103395A (bg) 2000-02-29

Family

ID=26548679

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103395A BG103395A (bg) 1996-11-13 1999-05-12 Производни на бензенсулфонамида и лекарства, които ги съдържат

Country Status (17)

Country Link
EP (1) EP0943606A1 (bg)
JP (1) JPH10195038A (bg)
KR (1) KR20000053254A (bg)
CN (1) CN1244859A (bg)
AU (1) AU716395B2 (bg)
BG (1) BG103395A (bg)
BR (1) BR9712763A (bg)
CA (1) CA2271673A1 (bg)
CZ (1) CZ169399A3 (bg)
EA (1) EA199900460A1 (bg)
ID (1) ID21835A (bg)
IL (1) IL129574A0 (bg)
NO (1) NO992316L (bg)
PL (1) PL333287A1 (bg)
SK (1) SK61199A3 (bg)
TR (1) TR199900984T2 (bg)
WO (1) WO1998021177A1 (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718586A4 (en) * 2004-01-30 2007-11-28 Great Lakes Chemical Corp METHODS AND SYSTEMS FOR PRODUCTION, COMPOSITIONS, SURFACTANTS, MONOMERIC UNITS, METAL COMPLEXES, PHOSPHORIC ESTERS, GLYCOLS, AQUEOUS FILM-FORMING FOAMS (AFFF TYPE) AND FOAM STABILIZERS
WO2005074594A2 (en) * 2004-01-30 2005-08-18 Great Lakes Chemical Corporation Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
EP1718723A4 (en) * 2004-01-30 2012-08-08 Du Pont METHODS AND SYSTEMS FOR PRODUCTION, COMPOSITIONS, SURFACTANTS, MONOMERIC UNITS, METAL COMPLEXES, PHOSPHORIC ESTERS, GLYCOLS, AQUEOUS FILM-FORMING FOAMS (AFFF TYPE) AND FOAM STABILIZERS
EP1718721A4 (en) * 2004-01-30 2012-08-08 Du Pont PRODUCTION PROCESSES AND SYSTEMS, COMPOSITIONS, TENSIDES, MONOMER UNITS, METAL COMPLEXES, PHOSPHATESTER, GLYCOLS, AQUEOUS FILM-FORMING FOAMS AND FOAM STABILIZERS
EP1942103A1 (en) * 2005-09-27 2008-07-09 Kaneka Corporation Method for producing optically active benzylamine derivative
JP2011088825A (ja) * 2008-01-16 2011-05-06 Kaken Pharmaceutical Co Ltd 鼻閉症治療用経粘膜投与製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd （２−チエニル）アルカン酸誘導体

Also Published As

Publication number Publication date
CN1244859A (zh) 2000-02-16
NO992316L (no) 1999-07-12
EP0943606A1 (en) 1999-09-22
SK61199A3 (en) 1999-11-08
ID21835A (id) 1999-08-05
IL129574A0 (en) 2000-02-29
PL333287A1 (en) 1999-11-22
CA2271673A1 (en) 1998-05-22
CZ169399A3 (cs) 1999-11-17
BR9712763A (pt) 1999-12-21
TR199900984T2 (xx) 1999-07-21
WO1998021177A1 (fr) 1998-05-22
KR20000053254A (ko) 2000-08-25
NO992316D0 (no) 1999-05-12
AU716395B2 (en) 2000-02-24
EA199900460A1 (ru) 2000-02-28
JPH10195038A (ja) 1998-07-28
AU4964597A (en) 1998-06-03

Similar Documents

Publication Publication Date Title
BE2018C008I2 (bg)
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
IL178350A0 (en) Vitamin d derivatives
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
PL356237A1 (en) Pyrimidine derivatives as selective inhibitors of cox-2
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
AU1498295A (en) MDR resistance treatment
ATE285410T1 (de) Naphthyridinderivate oder salze davon
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
IL110831A0 (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
BG103395A (bg) Производни на бензенсулфонамида и лекарства, които ги съдържат
ES2008962A6 (es) Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
ES8504731A1 (es) Un procedimiento para preparar antra 1,9-cd-7pirazol-6(2h)-onas
HUP0204080A2 (hu) 3-Amino-1-fenil-H[1,2,4]triazol új, elágazó szénláncokat tartalmazó amino-csoporttal helyettesített származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK0420224T3 (da) Anthihepatopatisk middel
ES528461A0 (es) Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri
ES8604843A1 (es) Un metodo para la preparacion de un derivado de acetileno
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
ES463228A1 (es) Procedimiento para preparar quinolinonas
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
EP0461264A4 (en) Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.